TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/25/24 17:30 | 3/21/24 | ACLX | Arcellx, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Carroll Jill | PA | D | S | -35,576 | 70.55 | 0 | -504 | -25 | 1,479 | I | |||||||||||||||
12/18/23 16:47 | 12/14/23 | ACLX | Arcellx, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Carroll Jill | PA | D | S | -24,774 | 49.13 | 0 | -504 | -20 | 1,983 | I | |||||||||||||||
6/2/23 16:56 | 5/31/23 | ACLX | Arcellx, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Carroll Jill | PA | D | S.m | -14,213 | 41.71 | 0 | -341 | -12 | 2,488 | I | |||||||||||||||
5/15/23 18:18 | 5/11/23 | ACLX | Arcellx, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Carroll Jill | PA | D | S | -28,736 | 45.01 | 0 | -638 | -18 | 2,828 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |